Home›Compare›MangoRx vs Noom

MangoRx vs Noom: Which Is Better?

Head-to-head comparison of MangoRx and Noom based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Noom scores higher overall in our independent evaluation (59.8/100 vs 58/100), leading on trust & safety, experience, reputation. MangoRx comes out ahead on value, product range.

58

MangoRx is the Dallas-based men's health telehealth brand of Nasdaq-listed Mangoceuticals, selling compounded ED, hair-loss and oral semaglutide products alongside injectable and oral (Kyzatrex) testosterone.

Visit MangoRx
60
Noom
Fair

Psychology-driven digital weight management platform combining behavioral coaching with GLP-1 medication prescribing, valued at $3.7B.

Visit Noom

Score Breakdown

DimensionMangoRxNoom
Overall Score58/10059.8/100 ✓
Trust & Safety30%55/10065/100 ✓
Value25%62/100 ✓60/100
Experience20%58/10070/100 ✓
Product Range15%66/100 ✓35/100
Reputation10%45/10060/100 ✓

At a Glance

Founded20212008
HeadquartersDallas, TXPrinceton, NJ
Publicly tradedYes (MGRX)No
Treatment categories52
Treatments listed58
Starting price$50/mo$17/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryMangoRxNoom
Hormone Therapy$99
Injectable TRT (testosterone cypionate)
$69–$149
Noom HRTRx (Menopause Hormone Therapy)
Weight Loss / GLP-1$299
Slim (compounded oral semaglutide ODT)
$17–$43
Noom Weight (Behavioral Only)

MangoRx

+Injectable TRT program priced at $99/month with doctor visits, lab work and medication included (per February 2026 company release and current site listing)
+Offers a branded FDA-approved oral testosterone option (Kyzatrex-based 'Prime') alongside compounded injectable TRT, which few small men's-health platforms carry
+Public-company SEC disclosures make ownership, pharmacy relationships and finances unusually visible for a brand this size
−Going-concern risk: $228,688 cash on hand at June 30, 2026 against a six-month net loss of $4.7M, per its Q2 2026 10-Q
−Compounded products are filled by Epiq Scripts, a pharmacy majority-owned (52%) by the CEO, a related-party arrangement
−Very small patient base: Q2 2026 revenue of $68,757, down 59% year over year, and only 18 Trustpilot reviews
Read the full MangoRx review →

Noom

+Best-in-class behavioral change platform with published clinical backing and 4.7-star App Store rating
+Multiple GLP-1 price tiers including unique microdose program from $49/mo
+Strong brand recognition: $3.7B valuation, 18 years of operation, backed by Sequoia/Silver Lake
−$56M class action settlement over autorenewal/cancellation practices; BBB 'D' rating with 1,200+ complaints
−Coaching quality criticized as automated/templated rather than personalized
−Microdose tiers are priced per-plan rather than flat, so the advertised low price is not the price most patients pay
Read the full Noom review →

MangoRx vs Noom — FAQ

Is MangoRx better than Noom?

▾

Noom scores higher overall in our independent evaluation (59.8/100 vs 58/100), leading on trust & safety, experience, reputation. MangoRx comes out ahead on value, product range.

Is MangoRx or Noom cheaper?

▾

Noom has the lower starting price (from $17/mo vs $50/mo for MangoRx). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do MangoRx and Noom both offer?

▾

Both platforms treat Hormone Therapy, Weight Loss / GLP-1. MangoRx covers 5 treatment categories total and Noom covers 2.

Still deciding?

MangoRx alternativesNoom alternativesTake the Match Quiz